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O B J E C T I V E S The aim of this study was to analyze the geometric pattern of hypertrophy (HT) in
patients with asymmetrical septal hypertrophic cardiomyopathy (HCM) using cardiac magnetic resonance
(CMR) and to test the hypothesis that at least in some patients, the HT follows a longitudinal spiral pattern.
B A C KG ROUND The highly heterogeneous phenotypic expression of HCM is a well-known
phenomenon. CMR has emerged as a robust 3-dimensional (3D) tomographic imaging technique that
is increasingly used to explore phenotypic expression.
METHOD S Short-axis cine CMR was used to study the 3D extent of HT (i.e., radial, circumferential,
and longitudinal extent, as well as the relation between circumferential and longitudinal extent).
Inclusion criteria were septal wall thickness (WT) 15 mm and septal to free wall WT ratio 1.3.
R E S U L T S CMR was performed in 132 patients. Maximal WT was 22  5 mm, with a circumferential
extent of 131  51°, and a longitudinal extent of 64  19%, resulting in a hypertrophied left ventricular
(LV) surface of 26  15%. Linear regression analysis showed in 86% of patients a consistent course of
HT along the longitudinal direction. The HT invariably started at the basal anteroseptum and rotated,
except in 2 patients, in a counterclockwise direction (CC-spiral patients) with a mean global rotation of
116  68° (range 5° to 350°). After the CC-spiral patients were divided according to magnitude of
rotation quartiles (Q1: 5° to 70°, Q2: 75° to 105°, Q3: 110° to 150°, and Q4: 155° to 350°), Q4 patients were
signiﬁcantly older and had more LV outﬂow tract obstruction and hypertension than patients without
the spiraling pattern. In 11 patients, continuation of HT into an apical form of HCM was found.
CONC L U S I O N S Using 3D analysis, we found that the majority of patients with asymmetrical septal
HCM in fact showed a spiral pattern of HT following a counterclockwise (or “left-handed”) spiral trajectory.
The variation in magnitude of rotation among patients, however, was highly variable. Further research is
warranted to better understand the signiﬁcance of the current ﬁndings, in particular to relate them to the
genetic and morphological substrate, hemodynamic consequences, and patient outcome. (J Am Coll
Cardiol Img 2012;5:702–11) © 2012 by the American College of Cardiology Foundation
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703ypertrophic cardiomyopathy (HCM) is
usually characterized by the presence of a
nondilated, asymmetrically hypertrophied
left ventricle (LV), but the phenotypic ex-
ression is highly heterogeneous (1,2). In an at-
empt to find clinical implications for different
henotypic expressions, pathological studies and
chocardiography have been used to look at patterns
f LV hypertrophy (2–4). In the last decade,
ardiac magnetic resonance (CMR) has emerged as
robust imaging technique that provides detailed
nformation about the presence, location, and dis-
ribution of hypertrophy in areas not well assessable
y echocardiography (5,6).
See page 712
The first aim of this study was to describe the
pattern of hypertrophy by CMR in radial, longitu-
dinal, and circumferential directions. Second, based
on CMR observations in patients with asymmetri-
cal septal HCM, we raised and tested the hypoth-
esis that the pattern of hypertrophy describes a
counterclockwise spiral (CC-spiral) in the longitu-
dinal direction when viewed from the LV apex
along the basal to apical direction (7). Finally, we
evaluated whether the longitudinal course of hyper-
trophy had an influence on functional, clinical, and
demographic parameters.
M E T H O D S
Study population. Of 150 patients with HCM
eferred for CMR between January 2007 and
ecember 2010, asymmetrical septal HCM was
iagnosed in 137 patients (n  71 in Leuven,
elgium, and n  66 in Pisa, Italy), based on the
resence of a septal wall thickness (WT) 15
m and a septal to free wall WT ratio 1.3 in
he absence of other disease that could justify the
agnitude of hypertrophy (1,2). Left ventricular
utflow tract (LVOT) obstruction was defined as
peak resting gradient 30 mm Hg on Doppler
chocardiography (8). Another 5 patients were
xcluded because of “end-stage” HCM (n  4)
nd healed transmural anterior infarction (n  1).
he decision for genetic testing was left at the
iscretion of the referring clinicians. Written
nformed consent was obtained for all patients,
nd the study was approved by the local ethics
eview board of the hospitals.
CMR protocol and analysis. Studies were performed
on 1.5-T CMR scanners using dedicated cardiacsoftware, phased-array surface receiver coil, and
electrocardiogram triggering (Online Appendix).
The protocol consisted of cine imaging in the
cardiac vertical and horizontal long-axis, short-axis,
and 3-chamber view. In the short-axis direction, the
LV was completely encompassed. Late gadolinium
enhancement imaging was performed 10 to 20 min
after intravenous contrast agent injection to assess
the presence of myocardial fibrosis (9).
CMR studies were analyzed off-line using in-
house–developed cardiac-dedicated software (Car-
dioviewer, UZ Leuven, Belgium), including assess-
ment of LV volumes, mass and ejection, hypertrophy
analysis, and assessment of myocardial fibrosis (On-
line Appendix). The extent of hypertrophy was
assessed in radial, longitudinal, and circumferential
direction using the short-axis cine images (Fig. 1).
A modified centerline technique with 180 chords
was used for assessment of end-diastolic myocardial
WT (10). A short-axis slice was considered hyper-
trophied (i.e., H-slice) if chords had a WT
13 mm (12 mm for women) (11). A
minimum of 12 positive chords were nec-
essary to consider a short-axis slice hyper-
trophied, and the chord with the maximal
WT was determined by the radial extent of
hypertrophy (Fig. 2). This was performed
for all short-axis slices starting with the
most basal slice (defined as n°1) and was
used to determine maximal WT and septal
to free wall ratio per patient. The circum-
ferential extent of hypertrophy, presented
in degrees, was expressed as the angle
between the limits of hypertrophy. The longitudinal
extent of hypertrophy was expressed as a percentage
dividing the number of H-slices by the total num-
ber of short-axis slices. The global extent of hyper-
trophy was defined as the hypertrophied endocar-
dial surface and expressed as the percentage of total
LV surface.
To test our study hypothesis, a linear regres-
sion analysis was used to evaluate the relation of
hypertrophy in longitudinal and circumferential
directions, thus not only taking into account the
global longitudinal rotation of hypertrophy but
also the rotational angle between consecutive
short-axis slices, assuming that the rotational
angle changes progressively as it is moving from
base to apex. This was achieved by measuring the
angle (“slice angle”) between the geometric center
of hypertrophy of an H-slice and the 0° reference
defined as the intersection of the vertical long-
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704This approach allowed spatial location of the
hypertrophy and calculation of the rotation per
slice (°/slice) and global rotation (°). A counter-
clockwise rotation was attributed a positive value
Figure 2. Modiﬁed Centerline Chord Technique to Assess Exten
Following delineation of endocardial and epicardial borders, a mid-
the measurement of myocardial WT. Four representative short-axis
The top middle panels show the intermediate images between the
Slice
Angle
0º
RV
LV
LE
RECE
Figure 1. Scheme of Analysis of 3-Dimensional Extent of
Hypertrophy
Radial extent (RE) represents maximal wall thickness (WT) per
slice, circumferential extent (CE) represents the angle between
limits of hypertrophy (red lines) per slice, and longitudinal
extent (LE) represents the number of hypertrophied (H)-slices.
The slice angle represents the angle between the geometric
center of hypertrophy (C) and reference point (0°) (i.e., intersec-
tion of vertical long-axis [VLA] with anterior left ventricular [LV]
wall [green lines]). RV  right ventricle.extracted borders, mid-ventricular centerline, and the 180 chords are sh(criterion 1), and an R2 value 0.7 on linear
regression analysis was considered to reflect a
good linear fit (criterion 2). Patients fulfilling
neither of the 2 criteria were classified as non-
spiral (N-spiral), whereas those fulfilling both
criteria were considered as having a CC-spiral
pattern. Finally, in patients with concomitant
concentric apical HCM, the most apical noncon-
centric H-slice was used for calculation of global
rotation of hypertrophy.
Statistical analysis. Continuous variables are ex-
pressed as mean  SD. Categorical variables are
expressed as frequency with percentage. One-way
analysis of variance with post hoc Bonferroni anal-
ysis was used to compare continuous variable dif-
ferences among patients in the N-spiral and CC-
spiral groups. The chi-square test was used to
compare noncontinuous variables expressed as pro-
portions, and the Fisher exact test was used when-
ever 1 or more cells in the comparison table had an
expected frequency of 5. The Pearson correlation
(r) was used to assess the relations of demographic
and clinical characteristics with hypertrophy extent.
Linear regression analysis with correlation coeffi-
cient (R2) calculation was used to test the rela-
ionship between slice angle and slice number.
ll tests were 2-tailed at a 5% significance level.
tatistical analysis was performed using SPSS
oftware for Windows (version 18.0, SPSS Inc.,
hicago, Illinois).
Hypertrophy
ricular line was deﬁned. Next 180 chords were deﬁned, allowing
es from the LV base (top left) to the apex (top right) are shown.
base (top left) and apex (top right). In the bottom panels, thet of
vent
imag
LVown. Abbreviations as in Figure 1.
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705R E S U L T S
Patient characteristics and conventional analysis. The
ean age was 50  18 years (range 14 to 85 years;
1% men) (Table 1). A familial history of sudden
ardiac death was present in 26 patents (20%), and
6 patients (12%) had experienced at least 1 episode
f unexplained syncope. Dyspnea (New York Heart
ssociation [NYHA] functional class II to IV) was
resent in 55 patients (42%). LV ejection fraction
as 69  9%. LVOT obstruction was present in 38
atients (29%). In 13 patients (10%), concomitant
pical HCM was detected on CMR. Late gadolin-
um enhancement was present in 79 patients (60%).
n 35 patients with genetic testing, gene mutations
ere found in 19 (54%).
3-dimensional extent of hypertrophy. The extent of
hypertrophy was highly variable, involving 6% to
76% of the LV surface (mean 26  15%). In the
Table 1. Demographic, Clinical, Conventional, and
Hypertrophy Analysis Parameters for the
Studied Population (N  132)
Age, yrs 50 18
Men 94 (71)
Maximal WT (radial extent), mm 22 5
Septum to free wall ratio 2.8 0.7
LVOT obstruction at rest, 30 mm Hg 38 (29)
Concomitant apical form 13 (10)
Family SCD 26 (20)
NYHA functional class
I 77 (58)
II 41 (31)
III–IV 14 (11)
Syncope 16 (12)
Systemic hypertension 40 (30)
LV mass, g 191 68
LV mass index, g/m2 103 33
EDV, ml 150 36
ESV, ml 47 21
EF, % 69 9
LGE presence, % 79 (60)
No. of total slices available 11 1
No. of H-slices 7 2
Longitudinal extent, % 64 19
Circumferential extent, ° 131 51
Circumferential extent—nonconcentric, ° 122 39
Global rotation, ° 103 71
Hypertrophied surface, % 26 15
R2 for slice no-slice angle linear model 0.8 0.2
Values are mean  SD or n (%).
EDV  end-diastolic volume; EF  ejection fraction; ESV  end-systolic
volume; H  hypertrophied; LGE  late gadolinium enhancement; LV  left
ventricular; LVOT  left ventricular outﬂow tract; NYHA  New York Heart
Association; SCD  sudden cardiac death; WT  wall thickness.radial direction, maximal WT ranged between 15and 39 mm (mean 22  5 mm) with septal to free
WT ratio of 1.7 to 5.6 (mean 2.8  0.7) (Fig. 3A).
The longitudinal extent of hypertrophy ranged
between 25% and 100% (mean 64  19%), but the
hypertrophy initiated always in the most basal LV
slices (i.e., short-axis slices 2 to 4) (Fig. 3A). No
discontinuity in the longitudinal extent of hypertro-
phy was found. The highest WT values were found
in the basal half of the LV (slices 2 to 6) (Fig. 3B).
The mean circumferential extent of hypertrophy,
when the concentric apical H-slides (58 slices, 7%
of H-slices) were excluded, was 122  39° and was
fairly constant from slice 3 to 11 (Fig. 4). Circum-
ferential discontinuity in hypertrophy was present
in 11 patients involving 24 of 891 H-slices (3%).
Relation between circumferential and longitudinal
extent of hypertrophy. The hypertrophy showed a
ongitudinal CC-spiral with a mean rotation 180°
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706(i.e., 18  20° in slice 1 to 218  29° in slice
11) (Fig. 5). With 0° as the reference, the spiral
started in the basal anterior to anteroseptal wall,
progressed toward a more septal position for the
following SA slices, and became inferoseptally or
inferiorly located for the apical slices. However, as
shown in Figure 5, SDs obviously increased the
further away they were from the LV base, indicative
of a large spread in magnitude of spiraling. Hyper-
trophy in LV inferolateral and anterolateral walls
were found in 8% and 3% of patients, respectively
(not taking into account the concentric apical
forms).
Slice
1 2 3 4 5 6 7 8 9 10 11 12
Circumferential extent non-concentric H slices Circumferential extent H slices
Circumferential Extent of Hypertrophy per Slice in
nal Direction
ferential extent for all H-slices is shown in red, and the circumfer-
nt for nonconcentric H-slices is shown in green. Slice 1 is the
l slice and slice 12 the most apical. Abbreviation as in Figure 1.
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Figure 5. Variation in Mean Slice Angle of Hypertrophy in
Longitudinal Direction
A close to linear increase in mean slice angle is seen from base
to apex together with increasing dispersion in the same direc-
tion. Slice 1 is the most basal slice and slice 12 the most apical.To investigate the relationship between circum-
ferential and longitudinal extent of hypertrophy,
linear regression analysis was performed. Although
18 patients showed no clear relationship (R2  0.3)
(i.e., defined as N-spiral group), the majority of
patients (i.e., 114 patients [86%]) showed R2  0.7
between slice angle and slice position. In 112
patients, global rotation was 0° (i.e., defined as
CC-spiral group), whereas 2 patients showed a
negative rotation of 70° and 60°, respectively.
aking into account the wide range in magnitude of
otation (range 5° to 350°, mean 116  68°),
C-spiral patients were classified using quartiles,
1: 5° to 70°, Q2: 75° to 105°, Q3: 110° to 150°,
nd Q4: 155° to 350° (Table 2, Fig. 6). Examples of
ifferent HCM patterns are shown in Figure 7 and
nline Videos 1A, 1B, and 1C.
Relation of nonspiral/spiral patterns with demographic,
clinical, and conventional CMR parameters. Global
rotation was related to age (r  0.35; p  0.0001).
In particular, Q4 CC-spiral patients (63  12
years-of-age) were older than the other groups and
presented a higher LV mass index (p  0.02) and a
higher frequency of hypertension (p  0.02)
(Table 2). Age, however, was not related to global,
longitudinal, and circumferential extent of hyper-
trophy. No significant differences between groups
were found regarding clinical characteristics like
family history of HCM or sudden cardiac death,
NYHA functional class, syncope, and prevalence of
atrial fibrillation. In genetically tested patients, gene
defects could not be attributed to specific pheno-
typic patterns, although remarkably, Q4 CC-spiral
patients yielded a much lower number of positive
tests than the other groups (Table 3).
Resting LVOT obstruction was more frequently
present in Q4 CC-spiral patients than N-spiral
patients (p 0.0001), an observation that could not
be explained by differences in maximal WT (i.e.,
radial extent) or hypertrophied surface. Remark-
ably, however, N-spiral patients showed more fre-
quently late gadolinium enhancement (88%) as
compared with CC-spiral groups (p  0.013),
whereas both groups tended to more frequently
have higher scores (i.e., grades 2 to 3) of late
gadolinium enhancement than the other groups.
No differences in enhancement patterns were ob-
served between groups (Table 4).
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707show a longitudinal counterclockwise (“left-handed”)
spiral rotation of hypertrophy. The degree of spi-
raling, however, is highly variable and ranges from
nearly straight to highly helical. In addition, the
magnitude of spiraling is positively related to age
and the occurrence of LVOT obstruction. Another
remarkable finding was the unexpected presence of
apical hypertrophy in 10% of patients with asym-
metrical septal HCM.
In agreement with previous work, we observed
that magnitude and spatial extent of hypertrophy
are highly variable in patients with asymmetrical
septal HCM (3,4,12,13). This heterogeneity is
prominent in radial and longitudinal directions,
whereas circumferential extent of hypertrophy is
fairly constant, involving approximately one third of
the LV circumference. Hypertrophy is typically
contiguous, with only 8% of patients showing dis-
continuity along circumferential direction, a per-
centage lower than reported in a previous study
(13). This discrepancy is likely explained by the
lower cutoff values for defining hypertrophy in our
study. Geometrically, the hypertrophy usually starts
Table 2. Demographic, Clinical, Conventional, and Hypertrophy
N-spiral Q1 (5–70
n 18 28
Age, yrs 41 15* 46 20
Men 10 (55.6) 23 (82)
Hypertension 2 (13) 4 (14)
LVOT obstruction at rest
(30 mm Hg)
2 (13) 1 (4)*
Family HCM 8 (43) 9 (32)
Syncope 2 (13) 3 (12)
LV mass, g 186 68 196 74
LV mass index, g/m2 95 30 105 35
EDV, ml 130 38 154 35
ESV, ml 39 20 54 23
EF, % 71 10 65 9
LGE presence 16 (88) 18 (63)
Septum to free wall ratio 3.4 0.7 2.9 0.8
Radial extent, mm 26 6 23 5
Total No. of slices, median 10.5 11
Longitudinal extent, % 70 18 59 21
Circumferential extent, ° 147 63 135 66
Hypertrophied surface, % 32 19 25 19
Global rotation, ° 26 29 49 19
Rotation/slice, °/slice — 9 4
R2 0.3 0.2 0.9 0.0
Values are mean  SD or n (%). *p  0.0001 versus Q4. †p  0.05 versus Q4.
CC  counterclockwise; HCM  hypertrophied cardiomyopathy; N-spiral  nin the basal anterior wall (78% of patients), and thebasal anteroseptum is invariably involved, showing
the greatest magnitude of hypertrophy. However,
the distribution of hypertrophy is highly variable
across the remainder of the LV wall, showing this
heterogeneity in phenotypic expression. Assess-
ing the relation between circumferential and
longitudinal extent of hypertrophy, we found a
close relation in most patients (86%), describing a
longitudinal spiral trajectory. Except in 2 pa-
tients, the spiral of hypertrophy followed a coun-
terclockwise trajectory with a mean rotation of
approximately 120° but a wide range of values (5°
to 350°). This corresponds to a spectrum of
possible trajectories ranging from a straight lon-
gitudinal course of hypertrophy without rotation
to a nearly complete helix of hypertrophy. These
findings are in line with previous studies investi-
gating the geometric pattern of hypertrophy in
large HCM populations (4,13). In the work by
Klues et al. (4) (n  600), the 4 most frequent
patterns of hypertrophy (representing 90% of
patients) could be explained by the presence of a
spiral. Recently, using CMR, Maron et al. (13)
alysis Parameters for N-Spiral and CC-Spiral Groups
CC-Spiral
Q2 (75–105°) Q3 (110–150°) Q4 (155–350
27 29 28
48 19† 50 13† 63 12‡
19 (70) 19 (66) 21 (75
7 (25) 5 (18) 16 (56
10 (38) 8 (26) 17 (60
9 (35) 10 (33) 8 (28
1 (5) 4 (13) 5 (18
167 52 180 62 221 78
87 28† 103 31 121 35
148 26 150 37 156 36
44 19 45 19 48 19
71 10 70 8 70 8
15 (56) 14 (50) 15 (54
2.6 0.6§ 2.6 0.7§ 2.8 0.6
21 5§ 20 4§ 23 4
11 10 11
54 14‡ 60 13 80 15
110 32 115 36 151 44
18 7*§ 21 9† 35 13
90 10 130 13 205 47
17 5 22 6 25 6
0.9 0.05‡ 0.9 0.08‡ 0.9 0.0
0.0001 versus N-spiral. §p  0.05 versus N-spiral.
iral; NA  not applicable; other abbreviations as in Table 1.An
p Value°) °)
† 0.0001
) 0.4
) 0.02
) 0.0001
) 0.9
) 0.8
0.06
0.02
0.15
0.15
0.12
) 0.013
0.001
0.002
0.0001
0.007
† 0.0001
NA
NA
7‡ 5‡ 0.0001
‡p (n  333) showed that the location of most
NS  nons
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708frequently hypertrophied and thickened segments
varied from base to apex (i.e., basally: anterior
and anteroseptal segments; mid level: anterosep-
tal and inferoseptal segments; and apically: infe-
Slice
1 2 3 4 5 6 7 8 9 10 11 12
Slice
1 2 3 4 5 6 7 8 9 10 11 12
Q1: 5-70º Q2: 75-105º Q3: 110-150º Q4: 155-350º
Slice
1 2 3 4 5 6 7 8 9 10 11 12
Differences in 3-Dimensional Extent Between N-Spiral and
Groups
in (A) radial extent and (B) circumferential extent and differences in
gle values between nonspiral (N-spiral) and counterclockwise spiral
groups. Slice 1 is the most basal slice and slice 12 the most apical.
piral group.rior and lateral segments), equally suggestive of aspiral trajectory of hypertrophy. Another inter-
esting finding of our study was that septal hyper-
trophy may extend toward a complete concentric
involvement of the LV apex in as many as 10% of
patients, suggesting that asymmetrical septal and api-
cal HCM are not completely separate phenotypes.
These observations give rise to several interesting
questions about morphological substrate, genotype-
phenotype relationship, hemodynamic consequences,
and patient outcome. Notably, it should be stated
that for most issues further investigation is war-
ranted. Although the morphological substrate in
HCM is well known, there is still disagreement
regarding which myocardial layer is predominantly
involved (14,15). In the LV wall the myofiber
orientation smoothly changes from an oblique
right-handed helix in the subendocardium to an
oblique left-handed helix in the subepicardium.
Thus, when viewed from the LV apex, the rotation
of fibers is indicated by the left hand fingers for the
subepicardium and vice versa for the subendocar-
dium (16). Whereas pathological studies analyz-
ing small ex vivo specimens hold inherent limi-
tations to study 3-dimensionally the anisotropic
structure of myocardium, diffusion-tensor CMR
has become a well-validated technique for non-
invasive characterization of myocardial fiber ori-
entation. The latter technique showed that fiber
disarray in patients with HCM predominantly
involved the left-handed subepicardial layer of
the hypertrophied septum (17). Aletras et al.
(18), using displacement encoding with stimu-
lated echoes CMR, reported an intramural func-
tional heterogeneity, with a noncontracting sub-
epicardial layer and largely preserved subendocardial
strain in the hypertrophied areas. Thus, our
finding of a CC-spiral is likely to be explained by
involvement of the left-handed subepicardial
layer. It can be hypothesized that the variability
in observed spiral angle among patients with
HCM may be caused by variation in subepicardial
myofiber angle. In analogy, apical HCM may
occur when the pathological fiber bundles involve
the LV apex.
An inverse relationship between age and the
degree of global rotation was observed. Notably,
patients with extensive spiraling were significantly
older, presented a higher frequency of hypertension
and greater LV mass index, and remarkably had a
lower number of positive tests for genetic defects.
Similarly, Binder et al. (19) showed that older40
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Figure 6.
CC-Spiral
Differences
(C) slice an
(CC-spiral)patients with HCM predominantly displayed a
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709sigmoid septal morphology, and they uncommonly
presented genetic perturbations.
Patients with extensive spiraling more frequently
showed LVOT obstruction than N-spiral patients,
although there was no difference in the magnitude
of hypertrophy. This finding supports that LVOT
obstruction is a complex phenomenon, in which
several factors other than degree of hypertrophy are
involved (e.g., reduced outflow tract cross-sectional
area, anterior mitral valve leaflet displacement,
elongation of mitral leaflets) (20,21). It can be
hypothesized that myocardial fibers in patients with
extensive spiraling have a more circumferential fiber
course and thus impinge more on the LVOT
during cardiac contraction.
Study limitations. The current findings are strictly
valid for patients with asymmetrical septal HCM
and cannot be extrapolated to other HCM forms.
Using septal to free wall WT ratio 1.3 as an
additional inclusion criterion, we might have
excluded HCM with laterobasal wall involve-
ment. To evaluate the relation between circum-
ferential and longitudinal extent of hypertrophy,
we used the geometric center of hypertrophy for
each short-axis slice. This center, however, does
not necessarily coincide with the most hypertro-
Figure 7. Volume-Rendered Images Presenting 3 Different Patte
Patient with hypertrophic cardiomyopathy (HCM) with a low ma
hypertrophy (left) (Online Video 1A), patient with HCM with a la
with spiral HCM ending in an apical form of HCM (right) (Online
left-handed pattern (i.e., indicated by the left hand ﬁngers), corr
Upper view (upper panels) and side view (lower panels). Hyper
ventricular; other abbreviation as in Figure 1.phied part of the myocardium in that short-axisslice. For analysis of late gadolinium enhance-
ment images, we used a visual, semiquantitative
rather than quantitative approach. Moreover, ge-
netic testing in larger patient groups is needed to
more accurately assess the genotype-phenotype
relationship. Finally, patients were studied in 2
tertiary centers in Belgium and Italy. Given the
heterogeneity of HCM, it remains to be deter-
mined whether these findings are found in other
HCM populations around the world.
Table 3. Genetic Testing
N-Spiral
CC-Spiral
Q1
(5–70°)
Q2
(75–105°)
Q3
(110–150
No. of tests 8 6 5 7
Negative 3 2 2 2
MYBPC3 3 2 3* 3
MYH7 1 1 2* 2
CSRP3 1
TNNT2 1
*1 patient had 2 gene defects.
CSRP3  cysteine- and glycine-rich protein 3; MYBPC3  cardiac myosin-bindin
of Spiraling
ude of spiraling and nearly straight longitudinal course of
amount of spiraling (middle) (Online Video 1B), and patient
eo 1C). When viewed from the LV apex, the spiral follows a
nding to the anatomic course of subepicardial ﬁbers (16).
hy is shown in red. Ant  anterior; inf  inferior; RV  right°)
Q4
(155–350°)
9
8
1
g protein C; MYH7 rns
gnit
rge
Vid
espo
tropcardiac muscle myosin heavy chain 7 beta; TNNT2  troponin T type 2; other abbreviations as in Table 2.
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710C O N C L U S I O N S
Using a CMR-based 3-dimensional analysis of
hypertrophy in patients with asymmetrical septal
HCM, we found a CC-spiral of hypertrophy in the
majority of patients. Among patients, the magni-
tude of rotation, however, was highly variable.
Further research is warranted to better understand
Table 4. Frequency and Patterns of Myocardial LGE
N-spiral Q1 (5–70°)
LGE presence 16 (88) 18 (63)
Grade 1/2/3 1/8/7 8/4/4
Location LGE
Limited anterior 6 8
Limited inferior 1 1
Mixed anterior  inferior 3 4
Entire septum 2 2
Extensive LGE 3 3
 Extension to anterior wall 2 4
 Extension to apex 3 1
Values are n (%) or n.
Abbreviation as in Tables 1 and 2.Cardiol 1995;26:1699–708.
1
lation 1994;90:127–to relate them to the genetic and morphological
substrate, hemodynamic consequences, and patient
outcome.
Reprint requests and correspondence: Dr. Jan Bogaert,
Department of Radiology, UZ Leuven, Herestraat 49,
B-3000 Leuven, Belgium. E-mail: salvador.borgesneto@
CC-Spiral
Q2 (75–105°) Q3 (110–150°) Q4 (155–350°)
15 (56) 14 (50) 15 (54)
7/5/3 5/7/2 2/7/6
5 2 0
3 2 2
4 6 10
0 2 1
3 2 2
0 0 4
0 0 4the significance of the current findings, in particular dm.duke.edu.R E F E R E N C E S
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For additional information on CMR sequence
details and extended description of hypertro-
phy analysis and supplementary videos, please
see the online version of this article.
